NYDRAZID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nydrazid, and when can generic versions of Nydrazid launch?
Nydrazid is a drug marketed by Sandoz and Bristol Myers Squibb and is included in two NDAs.
The generic ingredient in NYDRAZID is isoniazid. There are five drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the isoniazid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nydrazid
A generic version of NYDRAZID was approved as isoniazid by OMNIVIUM PHARMS on June 26th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NYDRAZID?
- What are the global sales for NYDRAZID?
- What is Average Wholesale Price for NYDRAZID?
Summary for NYDRAZID
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 154 |
| Clinical Trials: | 2 |
| Patent Applications: | 4,112 |
| DailyMed Link: | NYDRAZID at DailyMed |
Recent Clinical Trials for NYDRAZID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Institute of Tropical Medicine, Belgium | Phase 3 |
| Medical Research Council | Phase 3 |
| IUATLD, Inc | Phase 3 |
US Patents and Regulatory Information for NYDRAZID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | NYDRAZID | isoniazid | INJECTABLE;INJECTION | 008662-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bristol Myers Squibb | NYDRAZID | isoniazid | TABLET;ORAL | 008392-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
